Global outcome ‐ need for restraint or seclusion · people with psychosis‐induced aggression
HALOPERIDOL + PROMETHAZINE showed no clear difference in global state: Needing restraints or seclusion‐ by 2 hours compared with BENZODIAZEPINES ‐ MIDAZOLAM (moderate certainty).
1 finding from 1 review
Adverse effect: Specific ‐ Death · people with psychosis‐induced aggression
1 finding from 1 review
Not discharged from hospital · people with psychosis‐induced aggression
HALOPERIDOL + PROMETHAZINE showed no clear difference in service outcomes: Not discharged ‐ compared with BENZODIAZEPINES ‐ MIDAZOLAM (high certainty).
1 finding from 1 review
Specific behavioursAggression · people with psychosis‐induced aggression
1 finding from 1 review
no estimate extracted
4 participants
GRADE not reported
Economic outcomes: Cost of care · people with psychosis‐induced aggression
1 finding from 1 review
Catatonia: clinically important change in catatonia symptoms (improved at least 50% on the VAS) · catatonia in people with schizophrenia or SMI
It is very uncertain whether lorazepam changes catatonia: clinically important change in catatonia symptoms… compared with oxazepam (very low certainty).
1 finding from 1 review
Duration of hospital stay (days) for 'rescue' therapy · catatonia in people with schizophrenia or SMI
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Satisfaction with care: clinically important change in satisfaction by informal care‐givers · catatonia in people with schizophrenia or SMI
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Satisfaction with care: clinically important change in satisfaction by recipients of care · catatonia in people with schizophrenia or SMI
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Global state: clinically important change in global state · catatonia in people with schizophrenia or SMI
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects: clinically important adverse effectsassessed by: number of participants with a delayed memory deficitStudy duration: 4 weeks · catatonia in people with schizophrenia or SMI
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
General functioning: clinically important change in specific aspects of functioning, such as life skills ‒ as defined by each of the studies · catatonia in people with schizophrenia or SMI
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found